These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19455070

  • 1. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
    Lindh-Astrand L, Brynhildsen J, Hoffman M, Hammar M.
    Menopause; 2009; 16(6):1213-7. PubMed ID: 19455070
    [Abstract] [Full Text] [Related]

  • 2. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
    Col NF, Guthrie JR, Politi M, Dennerstein L.
    Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
    [Abstract] [Full Text] [Related]

  • 3. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women.
    Blümel JE, Chedraui P, Baron G, Belzares E, Bencosme A, Calle A, Danckers L, Espinoza MT, Flores D, Gomez G, Hernandez-Bueno JA, Izaguirre H, Leon-Leon P, Lima S, Mezones-Holguin E, Monterrosa A, Mostajo D, Navarro D, Ojeda E, Onatra W, Royer M, Soto E, Tserotas K, Vallejo S, Collaborative Group for Research of the Climacteric in Latin America (REDLINC).
    Menopause; 2011 Jul; 18(7):778-85. PubMed ID: 21407137
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled study of taper-down or abrupt discontinuation of hormone therapy in women treated for vasomotor symptoms.
    Lindh-Astrand L, Bixo M, Hirschberg AL, Sundström-Poromaa I, Hammar M.
    Menopause; 2010 Jul; 17(1):72-9. PubMed ID: 19675505
    [Abstract] [Full Text] [Related]

  • 5. Knowledge of reproductive physiology and hormone therapy in 53- to 54-year-old Swedish women: a population-based study.
    Lindh-Astrand L, Brynhildsen J, Hoffmann M, Kjellgren KI, Hammar M.
    Menopause; 2007 Jul; 14(6):1039-46. PubMed ID: 17519805
    [Abstract] [Full Text] [Related]

  • 6. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women.
    Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL.
    Maturitas; 2005 Oct 16; 52(2):119-26. PubMed ID: 16186074
    [Abstract] [Full Text] [Related]

  • 7. Hormones down under: hormone therapy use after the Women's Health Initiative.
    Travers C, O'Neill SM, Khoo SK, King R.
    Aust N Z J Obstet Gynaecol; 2006 Aug 16; 46(4):330-5. PubMed ID: 16866795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Discontinuation of postmenopausal hormone therapy.
    Grady D, Sawaya GF.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():163-5. PubMed ID: 16414343
    [Abstract] [Full Text] [Related]

  • 10. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.
    Menopause; 2009 Dec 19; 16(5):888-91. PubMed ID: 19421076
    [Abstract] [Full Text] [Related]

  • 11. Type of menopause, patterns of hormone therapy use, and hot flashes.
    Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA.
    Fertil Steril; 2006 May 19; 85(5):1432-40. PubMed ID: 16566933
    [Abstract] [Full Text] [Related]

  • 12. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
    Haimov-Kochman R, Barak-Glantz E, Arbel R, Leefsma M, Brzezinski A, Milwidsky A, Hochner-Celnikier D.
    Menopause; 2006 May 19; 13(3):370-6. PubMed ID: 16735933
    [Abstract] [Full Text] [Related]

  • 13. Persistent hot flushes in older postmenopausal women.
    Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF.
    Arch Intern Med; 2008 Apr 28; 168(8):840-6. PubMed ID: 18443259
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Postmenopausal hormone therapy and migraine headache.
    Misakian AL, Langer RD, Bensenor IM, Cook NR, Manson JE, Buring JE, Rexrode KM.
    J Womens Health (Larchmt); 2003 Dec 28; 12(10):1027-36. PubMed ID: 14709191
    [Abstract] [Full Text] [Related]

  • 16. Duration not severity of the climacteric syndrome predicts resumption of hormone therapy after discontinuation: a prospective cohort study.
    Haimov-Kochman R, Barak-Glantz E, Ein-Mor E, Arbel R, Brzezinski A, Milwidsky A, Hochner-Celnikier D.
    Hum Reprod; 2006 Sep 28; 21(9):2450-4. PubMed ID: 16731546
    [Abstract] [Full Text] [Related]

  • 17. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
    Haskell SG, Bean-Mayberry B, Gordon K.
    Menopause; 2009 Sep 28; 16(3):494-9. PubMed ID: 19182695
    [Abstract] [Full Text] [Related]

  • 18. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.
    Seritan AL, Iosif AM, Park JH, DeatherageHand D, Sweet RL, Gold EB.
    Menopause; 2010 Mar 28; 17(2):410-5. PubMed ID: 20216277
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.